WINNIPEG, Manitoba, May 12, 2011 - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the “Company”) today reported its results for the first quarter 2011. The results highlight continued progress in the execution of IMRIS’s overall strategy, including the planned acceleration of product development investments. All figures are reported in US dollars.

2011 Highlights:

• IMRISNV sale to Utah’s University Hospital contributes to total backlog of $115.1 million
• Q1 revenues of $11.1 million reflecting quarterly variability and seasonality
• Q1 gross profit as a percentage of revenues of 40.3%
• Launch of two new products, IMRIS Intraoperative CT and AccuTrack Neuro Navigation System
• University Hospital in Utah becomes first medical facility to purchase two IMRIS systems
• Europe’s first IMRISneuro system unveiled at Tubingen Hospital in Germany
• World’s first IMRIScardio system launched at Brigham and Women’s Hospital

Read More...